Physiological and pharmacological implications of beta-arrestin regulation.
about
Morphine-induced physiological and behavioral responses in mice lacking G protein-coupled receptor kinase 6Allosteric Modulation of Chemoattractant ReceptorsAlterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant SchizophreniaG-protein-coupled receptor kinase 2 and endothelial dysfunction: molecular insights and pathophysiological mechanismsTargeting G protein coupled receptor-related pathways as emerging molecular therapiesRgs13 constrains early B cell responses and limits germinal center sizesLigand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathway.Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics.Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivoFunctional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.Biochemical basis of asthma therapy.Noradrenergic antidepressant responses to desipramine in vivo are reciprocally regulated by arrestin3 and spinophilin.Serine 363 is required for nociceptin/orphanin FQ opioid receptor (NOPR) desensitization, internalization, and arrestin signaling.Serotonin receptor signaling and regulation via β-arrestins.Morphine-induced MOR-1X and ASF/SF2 Expressions Are Independent of Transcriptional Regulation: Implications for MOR-1X SignalingTherapeutic potential of β-arrestin- and G protein-biased agonists.Neoclerodanes as atypical opioid receptor ligandsMechanisms of Biased β-Arrestin-Mediated Signaling Downstream from the Cannabinoid 1 Receptor.β-Arrestin 2 knockout mice exhibit sensitized dopamine release and increased reward in response to a low dose of alcohol.Endosomes: a legitimate platform for the signaling train.Development of functionally selective, small molecule agonists at kappa opioid receptors.Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer.β-arrestin-2 is an essential regulator of pancreatic β-cell function under physiological and pathophysiological conditions.Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists.G protein coupled receptors as allosteric proteins and the role of allosteric modulators.Functional selectivity of adenosine receptor ligandsImmunomodulation using agonists and antagonists: potential clinical applications.β-Arrestins in the immune systemAre GPCRs still a source of new targets?Seeking Ligand Bias: Assessing GPCR Coupling to Beta-Arrestins for Drug Discovery.Multiple functions of G protein-coupled receptor kinasesThe Multiple Waves of Cannabinoid 1 Receptor Signaling.Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling.β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.The neuroprotective effect of losartan through inhibiting AT1/ASK1/MKK4/JNK3 pathway following cerebral I/R in rat hippocampal CA1 region.Dual-Color Bioluminescence Analysis for Quantitatively Monitoring G-Protein-Coupled Receptor and β-Arrestin Interactions.G protein-coupled receptor kinase 6/β-arrestin 2 system in a rat model of dopamine supersensitivity psychosis.
P2860
Q24646270-F40BA252-D5B8-427B-9801-B68F32DB4916Q26747395-27EC14D7-05C6-42E6-87BD-CA53BF74EA3DQ26773403-C842424D-D549-4E37-91AD-A5B142E29BB9Q26786233-8ADDEC7D-746C-4A40-9CFA-178BD10F9B7EQ26829964-6118626F-3993-4DBB-85E9-F61D4D4BD205Q27331880-F9E677DE-FA6A-4807-A9DB-7FE61EDCDBCBQ28245037-5EECDEE2-4332-40C9-ACB6-B183B769C3BDQ30353387-CD34A9FF-5C79-4D1C-8FF2-CBBA732B3FF6Q33890786-34BA34DF-09A7-4E69-B66A-C0E9EDE3B4EFQ34098179-F06D4185-2914-4FFC-B9D4-9997A74E878DQ34311504-A0E08DC0-33AB-4A92-85F5-8BC313F5EAEAQ34402623-F849420E-8297-4644-91F4-A3C9B9B76AEFQ35264421-B9FDA2B5-EEFF-4428-9290-DBA769E5D727Q35312155-F2D9850B-41F6-457F-A67F-E9FC1B39B33EQ35856932-97056C26-CDFE-42C7-8720-A04C37C0AF8DQ36451963-089920B3-D18D-4EB6-AB5A-FC296531F080Q36647024-FCCA9FFC-1930-469E-B063-64A84FBC63C3Q36712009-6F0C77B3-AD5B-4549-95B7-6FDDF1CD18D8Q36773331-D4EA82D3-C2D6-4B28-82ED-92D919B79E7FQ36899819-B156DB93-7CA7-4F20-BB55-8A9C19D1BE03Q36947742-F0148A77-0085-49FE-AC66-C2D59D027064Q37281047-9C38562B-B24E-48DE-922C-3150E300D879Q37394435-E151BB72-B654-4A17-929D-5A7688297324Q37405071-03C0A7C8-3593-4BC9-A92F-8C183D5F650EQ37573308-8CA15C88-F4BA-4BAA-ABFD-BC5BC61A527DQ37630356-4F1C4962-A577-46D4-80BF-9BBC779A7D6DQ37634296-F198100D-71E3-4590-8EB9-80A0B8A2BFECQ37790693-4A64665E-6CBC-4A01-B84B-2113CCFD9A66Q37872220-70A8C211-58C8-4662-9095-643EE41FF2EEQ37965728-F5655CFD-1BD8-4080-897A-A9CDDD4E3B90Q38114223-7D20461B-5331-4A92-9834-CD905384C2F2Q38129012-728C73B8-B22A-4F9F-9946-38C3E9F15B39Q38465294-B69185F1-97FF-49CA-A635-FF305D4B2BA2Q38599397-8122E05E-FABB-45B2-8894-6A3C518B179EQ38874828-261C552A-FB60-4A11-8754-4E239262C70DQ40560867-31730511-71BA-4C33-AD48-C8A88FDF1CBEQ42557834-B62F416D-13FB-4D18-A578-7BFB358ECB6EQ48323135-C3FE3463-B235-4695-8396-AD7040842E1BQ49955340-2235286A-EB86-4BEB-A1F2-9FB7135656BFQ50578790-5F7BB7A9-2BA3-49DB-BEB5-18B8F83D7C83
P2860
Physiological and pharmacological implications of beta-arrestin regulation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Physiological and pharmacological implications of beta-arrestin regulation.
@en
Physiological and pharmacological implications of beta-arrestin regulation.
@nl
type
label
Physiological and pharmacological implications of beta-arrestin regulation.
@en
Physiological and pharmacological implications of beta-arrestin regulation.
@nl
prefLabel
Physiological and pharmacological implications of beta-arrestin regulation.
@en
Physiological and pharmacological implications of beta-arrestin regulation.
@nl
P2860
P1476
Physiological and pharmacological implications of beta-arrestin regulation
@en
P2093
Cullen L Schmid
P2860
P304
P356
10.1016/J.PHARMTHERA.2008.11.005
P50
P577
2008-12-06T00:00:00Z